A major limitation with traditional phage preparations is the variability in titer, salts, and bacterial contaminants between successive propagations. Here we introduce the Phage On Tap (PoT) protocol for the quick and efficient preparation of homogenous bacteriophage (phage) stocks. This method produces homogenous, laboratory-scale, high titer (up to 1010–11 PFU·ml−1), endotoxin reduced phage banks that can be used to eliminate the variability between phage propagations and improve the molecular characterizations of phage. The method consists of five major parts, including phage propagation, phage clean up by 0.22 μm filtering and chloroform treatment, phage concentration by ultrafiltration, endotoxin removal, and the preparation and stora...
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to a...
Therapeutic bacteriophages are emerging as a potential alternative to antibiotics and synergistic tr...
Blood-borne therapeutic phages and phage capsids increasingly reach therapeutic targets as they acqu...
This thesis describes an alternative bioprocess for bacteriophages involving room temperature co-pre...
We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation o...
The production of phages for therapeutic purposes demands fast, efficient and scalable purification ...
Antibiotic resistance of pathogenic bacteria has increased in recent years. When antibiotics do not ...
Future industrial demand for large quantities of bacteriophages e.g., for phage therapy, necessitate...
Due to the nascency of bacteriophage-based pathogen detection technologies, several practical hurdle...
We have developed a simple and efficient protocol for the isolation of good-quality recombinant phag...
Bacterial endotoxins have high immunogenicity. Phage biology studies as well as therapeutic phage ap...
Bacteriophages can be used in various applications, from the classical approach as substitutes for a...
Lipopolysaccharide (LPS, endotoxin, pyrogen) constitutes a very troubling contaminant of crude phage...
The increasing problem of antibiotic-resistant pathogens has put enormous pressure on healthcare pro...
Bacteriophages show great potential in many applications. Their abundance exceeds the bacterial popu...
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to a...
Therapeutic bacteriophages are emerging as a potential alternative to antibiotics and synergistic tr...
Blood-borne therapeutic phages and phage capsids increasingly reach therapeutic targets as they acqu...
This thesis describes an alternative bioprocess for bacteriophages involving room temperature co-pre...
We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation o...
The production of phages for therapeutic purposes demands fast, efficient and scalable purification ...
Antibiotic resistance of pathogenic bacteria has increased in recent years. When antibiotics do not ...
Future industrial demand for large quantities of bacteriophages e.g., for phage therapy, necessitate...
Due to the nascency of bacteriophage-based pathogen detection technologies, several practical hurdle...
We have developed a simple and efficient protocol for the isolation of good-quality recombinant phag...
Bacterial endotoxins have high immunogenicity. Phage biology studies as well as therapeutic phage ap...
Bacteriophages can be used in various applications, from the classical approach as substitutes for a...
Lipopolysaccharide (LPS, endotoxin, pyrogen) constitutes a very troubling contaminant of crude phage...
The increasing problem of antibiotic-resistant pathogens has put enormous pressure on healthcare pro...
Bacteriophages show great potential in many applications. Their abundance exceeds the bacterial popu...
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to a...
Therapeutic bacteriophages are emerging as a potential alternative to antibiotics and synergistic tr...
Blood-borne therapeutic phages and phage capsids increasingly reach therapeutic targets as they acqu...